Esomeprazole Magnesium
Product Images NDC 50436-3120

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 50436-3120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (50436 3120)

Label for Esomeprazole Magnesium delayed-release capsules, 40 mg strength, supplied in a 30 count package. The label shows NDC 50436-3120-1 and indicates the product is manufactured by Teva and labeled by Unit Dose Services, LLC, FL 33004. Storage instructions and multiple instances of drug and lot information are also shown.*

FDA Label Image

Logo (Image 01)

Chemical structure of Esomeprazole Magnesium showing its molecular arrangement as depicted in the image.*

FDA Label Image

Logo (Image 02)

FDA Label Image

Structural Formula (Image 03)

Chemical structure of Esomeprazole Magnesium, showing two molecules of the esomeprazole component complexed with magnesium and two water molecules (Mg2+ and 2 H2O). The structure includes pyridine and benzimidazole rings with methoxy and methyl substituents.*

FDA Label Image

Figure 2 (Image 04)

A line graph showing the percent maintained over a 6-month period for Esomeprazole Magnesium at 40 mg, 20 mg, and 10 mg doses compared to placebo. The y-axis represents percent maintained, and the x-axis represents time in months. Four lines depict data trends for each dosage and placebo, illustrating differences in maintenance rates over time.*

FDA Label Image

Figure 3 (Image 05)

A line graph depicting the percent maintained over a period of 6 months for Esomeprazole Magnesium at doses of 10 mg, 20 mg, and 40 mg compared to placebo. The y-axis represents percent maintained, while the x-axis shows time in months. The graph includes four lines representing each dose group and placebo, with sample sizes indicated in the legend.*

FDA Label Image

Figure 4 (Image 06)

A line graph showing the percent of patients symptom-free over 28 diary days. It compares three groups: Esomeprazole Magnesium 40 mg, Esomeprazole Magnesium 20 mg, and placebo, with both Esomeprazole groups showing higher symptom-free percentages compared to placebo over time.*

FDA Label Image

Figure 5 (Image 07)

A line graph showing the percent of patients symptom-free over a 28-day diary period. It compares three groups: Esomeprazole Magnesium 40 mg, Esomeprazole Magnesium 20 mg, and a placebo, with symptom-free rates increasing over time, higher in the Esomeprazole groups than placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.